Seale, AC;
Koech, AC;
Sheppard, AE;
Barsosio, HC;
Langat, J;
Anyango, E;
Mwakio, S;
... Berkley, JA; + view all
(2016)
Maternal colonisation with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal Kenya.
Nature Microbiology
, Article 16067. 10.1038/nmicrobiol.2016.67.
Preview |
Text (Article)
Walker_GBS_manuscript_3.4.16.pdf Download (416kB) | Preview |
Preview |
Text (Supplementary information)
Walker_GBS Supplementary Information_3.4.16.pdf Download (1MB) | Preview |
Preview |
Text (Figure 1)
Walker_Figure 1.pdf Download (220kB) | Preview |
Preview |
Text (Figure 2)
Walker_Figure 2.pdf Download (226kB) | Preview |
Preview |
Text (Figure 3)
Walker_Figure 3.pdf Download (199kB) | Preview |
Preview |
Text (Figure 4)
Walker_fig4_rerevised.pdf Download (517kB) | Preview |
Preview |
Text (Table S5)
Walker_Table S5 Exposures associated with maternal GBS colonisation.pdf Download (157kB) | Preview |
Spreadsheet (Table S16)
Walker_Table S16 S agalactiae isolates.csv Download (1MB) |
Abstract
Streptococcus agalactiae (Group B Streptococcus, GBS) causes neonatal disease and stillbirth, but its burden in sub-Saharan Africa is uncertain. We assessed maternal recto-vaginal GBS colonisation (7967 women), stillbirth and neonatal disease. Whole genome sequencing was used to determine serotypes, sequence types (ST), and phylogeny. We found low maternal GBS colonisation prevalence (934/7967, 12%), but comparatively high incidence of GBS-associated stillbirth and early onset neonatal disease (EOD) in hospital (0.91(0.25-2.3)/1000 births; 0.76(0.25-1.77)/1000 live-births respectively). However, using a population denominator, EOD incidence was considerably reduced (0.13(0.07-0.21)/1000 live-births). Treated cases of EOD had very high case fatality (17/36, 47%), especially within 24 hours of birth, making under-ascertainment of community-born cases highly likely, both here and in similar facility-based studies. Maternal GBS colonisation was less common in women with low socio-economic status, HIV infection and undernutrition, but when GBS-colonised, they were more likely colonised by the most virulent clone, CC17. CC17 accounted for 267/915(29%) of maternal colonising (265/267(99%) serotype III, 2/267(0.7%) serotype IV), and 51/73(70%) of neonatal disease cases (all serotype III). Trivalent (Ia/II/III) and pentavalent (Ia/Ib/II/III/V) vaccines would cover 71/73(97%) and 72/73(99%) of disease-causing serotypes respectively. Serotype IV should be considered for inclusion, with evidence of capsular switching in CC17 strains.
Type: | Article |
---|---|
Title: | Maternal colonisation with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal Kenya |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1038/nmicrobiol.2016.67 |
Publisher version: | http://dx.doi.org/10.1038/nmicrobiol.2016.67 |
Language: | English |
Additional information: | Copyright © 2016 Macmillan Publishers Limited. All rights reserved. |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > MRC Clinical Trials Unit at UCL |
URI: | https://discovery.ucl.ac.uk/id/eprint/1477456 |
Archive Staff Only
View Item |